PureForm Global Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Series A
- (Cancelled)
- Investors
-
1
PureForm Global General Information
Description
Producer of nature-identical cannabinoids intended for treating disease and promoting wellness. The company's products are pure and chemically identical to their plant-based counterparts and are manufactured using a proprietary process that produces pure, consistent, and stable compounds free from THC, pesticides, and impurities, enabling clients to access products for use in consumer and pharmaceutical applications.
Contact Information
Website
www.pureformglobal.comCorporate Office
- 5700 Melrose Avenue
- Suite 208
- Los Angeles, CA 90038
- United States
Corporate Office
- 5700 Melrose Avenue
- Suite 208
- Los Angeles, CA 90038
- United States
PureForm Global Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series A) | Cancelled | Generating Revenue | ||||
| 3. Later Stage VC | 01-Dec-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 01-May-2019 | $2.6M | $8.6M | Completed | Generating Revenue | |
| 1. Angel (individual) | $6M | $6M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
PureForm Global Patents
PureForm Global Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023086447-A2 | A method for the synthesis of cannabinol | Inactive | 12-Nov-2021 | ||
| WO-2023086447-A3 | A method for the synthesis of cannabinol | Inactive | 12-Nov-2021 | ||
| WO-2021050429-A1 | Topical composition for treatment of pain | Inactive | 10-Sep-2019 | ||
| EP-3676238-A1 | Synthetic cannabidiol compositions and methods of making the same | Inactive | 01-Sep-2017 | ||
| US-11267774-B2 | Synthetic cannabidiol compositions and methods of making the same | Active | 01-Sep-2017 | C07C13/21 |
PureForm Global Signals
PureForm Global Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority |
PureForm Global FAQs
-
When was PureForm Global founded?
PureForm Global was founded in 2015.
-
Where is PureForm Global headquartered?
PureForm Global is headquartered in Los Angeles, CA.
-
What is the size of PureForm Global?
PureForm Global has 14 total employees.
-
What industry is PureForm Global in?
PureForm Global’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is PureForm Global a private or public company?
PureForm Global is a Private company.
-
What is PureForm Global’s current revenue?
The current revenue for PureForm Global is .
-
How much funding has PureForm Global raised over time?
PureForm Global has raised $10.6M.
-
Who are PureForm Global’s investors?
has invested in PureForm Global.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process